Wells Fargo & Company Immucell Corp Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Immucell Corp stock. As of the latest transaction made, Wells Fargo & Company holds 1 shares of ICCC stock, worth $3. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 2,544
99.96%
Holding current value
$3
Previous $13,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ICCC
# of Institutions
29Shares Held
1.15MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA226KShares$823,4210.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL207KShares$756,3230.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny126KShares$458,3990.0% of portfolio
-
Bleichroeder LP New York, NY102KShares$370,8180.18% of portfolio
-
Morgan Stanley New York, NY66.8KShares$243,8780.0% of portfolio
About IMMUCELL CORP
- Ticker ICCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,746,860
- Market Cap $28.3M
- Description
- ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...